Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03004222 · ClinicalTrials.gov registry record · NA
A Study to Determine the Effectiveness of Utilizing Intraperitoneal Bupivacaine
A NA study, sponsored by Metro Health, Michigan.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT03004222: Completed NA study, sponsored by Metro Health, Michigan.
NCT03004222 is a NA study that has completed, run by Metro Health, Michigan. The registered enrollment target is 137 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03004222, a NA study, has completed, sponsored by Metro Health, Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
The purpose of this research is to determine if spraying a local anesthetic to the cecum after a laparoscopic appendectomy decreases the amount of narcotics (pain medicine) needed after surgery and reduces the time to discharge from the hospital.
Interventions
- DRUG Bupivacaine
- DRUG Placebos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03004222
The ClinicalTrials.gov registry entry for NCT03004222 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Metro Health, Michigan, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT03004222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03004222 about?
NCT03004222 is a clinical study titled "A Study to Determine the Effectiveness of Utilizing Intraperitoneal Bupivacaine". The purpose of this research is to determine if spraying a local anesthetic to the cecum after a laparoscopic appendectomy decreases the amount of narcotics (pain medicine) needed after surgery and reduces the time to discharge from the hospital.
What is the current status of trial NCT03004222?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2015-07. Estimated completion is 2017-11.
What interventions are being tested in trial NCT03004222?
The interventions under investigation include: Bupivacaine (DRUG), Placebos (DRUG).
Who is sponsoring clinical trial NCT03004222?
This trial is sponsored by Metro Health, Michigan, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.